-
Mashup Score: 6Chronicling the Extraordinary Career of Stephen R. Grobmyer, MD, FACS, in Breast Cancer Research, Surgery, and Treatment - 1 day(s) ago
In this installment of The ASCO Post’s Living a Full Life series, Stephen R. Grobmyer, MD, FACS, speaks about his clinical and research career in oncology, the challenges and rewards of moving to Abu …
Source: ascopost.comCategories: General Medicine NewsTweet
-
Mashup Score: 7Faculty - 7 day(s) ago
Register for Cleveland Clinic’s 8th Annual Cleveland Breast Cancer Summit: Collaborating for a Cure, Friday August 9, 2024 LIVE at the Intercontinental Hotel & Conference Center. This years summit will focus on the up to date reviews and treatment of early-onset breast cancer
Source: www.clevelandclinicmeded.comCategories: General Medicine NewsTweet-
Please join us for @ClevelandClinic Breast Cancer Summit https://t.co/aEEz4GV50g @HalleMooreMD @ZAlHilliMD @CShahMD @DrStephValente @AzkaAliMD @MeganKruseMD @AmandaMaggiotto ! https://t.co/oBcalaGxZn
-
-
Mashup Score: 4
Taletrectinib, an experimental oral next-generation tyrosine kinase inhibitor (TKI), has demonstrated robust clinical activity in the treatment of ROS1-positive non-small cell lung cancer (NSCLC).
Source: consultqd.clevelandclinic.orgCategories: General Medicine NewsTweet-
Novel Targeted Treatment for NSCLC Effective Across Multiple Regions and Populations https://t.co/qwCOOdEwTS via @clevelandclinic @n8pennell !
-
-
Mashup Score: 2Predicting Gastric Cancer Risk: A New EHR-Based Model - 24 day(s) ago
Listen as Dr. Kim explains how the model uses common clinical variables to flag high-risk patients who may benefit from endoscopic screening.
Source: my.clevelandclinic.orgCategories: General Medicine NewsTweet-
Predicting Gastric Cancer Risk: A New EHR-Based Model https://t.co/103DxH01VL via @clevelandclinic
-
-
Mashup Score: 5Changing Course in Treating Advanced Melanoma - 1 month(s) ago
Neoadjuvant immunotherapy improves outcomes
Source: consultqd.clevelandclinic.orgCategories: General Medicine NewsTweet-
Changing Course in Treating Advanced Melanoma https://t.co/pgajhwnYGD via @clevelandclinic
-
-
Mashup Score: 53Redefining Human Epidermal Growth Factor Receptor 2 Testing in Breast Cancer in the Era of Novel Antibody-Drug Conjugates | JCO Oncology Practice - 1 month(s) ago
The advent of next-generation antibody-drug conjugates (ADCs), particularly trastuzumab deruxtecan (T-DXd), has transformed our understanding of human epidermal growth factor receptor 2 (HER2) targetability for breast cancer (BC) treatment. Historically …
Source: ascopubs.orgCategories: General Medicine NewsTweet-
Redefining Human Epidermal Growth Factor Receptor 2 Testing in Breast Cancer in the Era of Novel Antibody-Drug Conjugates | @JCOOP_ASCO @OncoAlert Excellent article by @PTarantinoMD and colleagues to help us to undestand Her-2 testing now! https://t.co/M7SRZxtxDp https://t.co/6CGdslWDAy
-
-
Mashup Score: 3Registration - 1 month(s) ago
Register for Cleveland Clinic’s Comprehensive Cancer Center Medical Oncology Update 2025 on Wednesday June 18 at the Intercontinental Hotel and Conference Center in Cleveland OH
Source: www.clevelandclinicmeded.comCategories: General Medicine NewsTweet-
Looking forward to the oncology update on June 18th @ClevelandClinic https://t.co/zVUyqTGg1y https://t.co/umyoA5vAFC
-
-
Mashup Score: 13Health Care, Physics, and Finance: The Complex Equation of Outpatient CAR T-Cell Therapy | JCO Oncology Practice - 2 month(s) ago
In this issue of JCO Oncology Practice, Majhail et al 1 describe their organization’s experience with outpatient chimeric antigen receptor T-cell (CAR-T) cell therapy using a remote patient monitoring (RPM) system. The continued growth of cellular immunotherapy with its unique delivery model requires treatment centers administering this type of therapy to overcome obstacles related to physical infrastructure, technical resources, insurance coverage, and patient access. Related to access, Majhail et al 1
Source: ascopubs.orgCategories: General Medicine NewsTweet-
Health Care, Physics, and Finance: The Complex Equation of Outpatient CAR T-Cell Therapy | @JCOOP_ASCO #jcoop https://t.co/8HUvpqgarE https://t.co/rCNSyqMffR
-
-
Mashup Score: 1From Blood Sugar to Blood Cancer: Surprising Benefits of GLP-1s - 2 month(s) ago
Tune in to hear how GLP-1s, best known for managing diabetes and obesity, may hold promise for cancer prevention and what this could mean for future cardio-oncology care.
Source: my.clevelandclinic.orgCategories: General Medicine NewsTweet-
From Blood Sugar to Blood Cancer: Surprising Benefits of GLP-1s https://t.co/LMB3ZiUCnc via @clevelandclinic @CleClinicMD
-
-
Mashup Score: 136Opportunities for Artificial Intelligence in Oncology: From the Lens of Clinicians and Patients | JCO Oncology Practice - 2 month(s) ago
Much work has been published on artificial intelligence (AI) and oncology, with many focusing on an algorithm perspective. However, very few perspective articles have explicitly discussed the role of AI in oncology from the perspectives of the …
Source: ascopubs.orgCategories: General Medicine NewsTweet-
Thank you @anantm and his colleagues from @EmoryUniversity for this must read - excellent review for clinicians on Artificial Intelligence https://t.co/PUd0iD60xT @JCOOP_ASCO @OncoAlert @EthicsdoctorP https://t.co/BYitJosdzX
-
It was my pleasure to talk to my friend and colleague @grobmys https://t.co/uxZxPyj9oN @CCAD @CleClinicMD Remarkable journey of improving cancer care in the US and globally !! https://t.co/ZXqQB5tG4V